Kazia Therapeutics Limited American Depositary Shares
Symbol: KZIA (NASDAQ)
7.08
▼ (-4.19%) -0.310
Company Description:
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
Key Stats
- Today's Open: $7.35
- Today's High: $7.445
- Today's Low: $6.871
- Today's Volume: 26.49K
- Yesterday Close: $7.39
- Yesterday High: $7.39
- Yesterday Low: $6.95
- Yesterday Volume: 26.62K
- Last Min Volume: 1
- Last Min High: $7.08
- Last Min Low: $7.08
- Last Min VWAP: $7.08
Company Profile
- Name: Kazia Therapeutics Limited American Depositary Shares
- Website: https://www.kaziatherapeutics.com
- Listed Date: 1999-01-06
- Location: NEW SOUTH WALES 2113, C3
- Market Status: Active
- CIK Number: 0001075880
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $12.35M
- Round Lot: 100
- Outstanding Shares: 1.67M
- Asset Type: ADRC
RECENT FILINGS FOR KZIA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-07 | 424B3 | View |
| 2025-10-07 | 424B3 | View |
| 2025-10-07 | 424B3 | View |
| 2025-10-07 | 6-K | View |
| 2025-10-02 | 424B3 | View |
| 2025-10-02 | 424B3 | View |
| 2025-10-02 | 424B3 | View |
| 2025-10-02 | 6-K | View |
| 2025-09-30 | F-1 | View |
| 2025-09-12 | SCHEDULE 13G/A | View |
| 2025-09-11 | 424B3 | View |
| 2025-09-11 | 424B3 | View |
| 2025-09-11 | 424B3 | View |
| 2025-09-11 | 6-K | View |
| 2025-08-14 | D | View |
| 2025-08-05 | SCHEDULE 13G/A | View |
| 2025-08-01 | 424B3 | View |
| 2025-08-01 | 424B3 | View |
| 2025-08-01 | 424B3 | View |
| 2025-08-01 | 6-K | View |
Latest News on KZIA